C116H233N21O9 — CID 159095877
2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol (PubChem CID 159095877) has the molecular formula C116H233N21O9 and a molecular weight of 2066.28 g/mol. Its IUPAC name is 2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol.
| Compound Name | 2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol |
|---|---|
| PubChem CID | 159095877 |
| Molecular Formula | C116H233N21O9 |
| Molecular Weight | 2066.28 g/mol |
| Exact Mass | 2064.84 |
| IUPAC Name | 2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol |
| SMILES | CC(C)CCN1CCC(C(C)(C)O)CC1.CC(C)CN1CC(N2CC(O)C2)C1.CC(C)CN1CC(N2CCC(O)C2)C1.CC(C)CN1CC(N2CCC(O)CC2)C1.CC(C)CN1CC(N2CCCC(O)C2)C1.CC(C)CN1CC(N2CCCC2)C1.CC(C)CN1CC(N2CCCCC2)C1.CC(C)CN1CC(N2CCNC(=O)C2)C1.CC(C)CN1CC(N2CCOCC2)C1.CC(C)CN1CC(O)(CN(C)C(C)(C)C(N)=O)C1 |
| InChI | InChI=1S/C13H27N3O2.C13H27NO.2C12H24N2O.C12H24N2.C11H21N3O.2C11H22N2O.C11H22N2.C10H20N2O/c1-10(2)6-16-8-13(18,9-16)7-15(5)12(3,4)11(14)17;1-11(2)5-8-14-9-6-12(7-10-14)13(3,4)15;1-10(2)7-13-8-11(9-13)14-5-3-12(15)4-6-14;1-10(2)6-13-7-11(8-13)14-5-3-4-12(15)9-14;1-11(2)8-13-9-12(10-13)14-6-4-3-5-7-14;1-9(2)5-13-6-10(7-13)14-4-3-12-11(15)8-14;1-10(2)7-12-8-11(9-12)13-3-5-14-6-4-13;1-9(2)5-12-6-10(7-12)13-4-3-11(14)8-13;1-10(2)7-12-8-11(9-12)13-5-3-4-6-13;1-8(2)3-11-4-9(5-11)12-6-10(13)7-12/h10,18H,6-9H2,1-5H3,(H2,14,17);11-12,15H,5-10H2,1-4H3;2*10-12,15H,3-9H2,1-2H3;11-12H,3-10H2,1-2H3;9-10H,3-8H2,1-2H3,(H,12,15);10-11H,3-9H2,1-2H3;9-11,14H,3-8H2,1-2H3;10-11H,3-9H2,1-2H3;8-10,13H,3-7H2,1-2H3 |
| InChIKey | KCQUUVMWRKRHSP-UHFFFAOYSA-N |
| XLogP | 8.02 |
| TPSA | 264.36 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 146 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2066.28 |
| LogP ≤ 5 | 8.02 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 28 |